Intrathecal drug delivery involves administering analgesic medications directly into the cerebrospinal fluid, thereby achieving targeted pain relief while minimising systemic side effects. This method ...
Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non–small-cell lung cancer. The safety of seasonal influenza ...
A study presented at the American Academy of Pain Medicine’s 26th annual meeting investigated methods for reducing the estimated $1 billion spent annually on pain care treatment in the United States ...
Alcyone's ThecaFlex DRx™ System is an implantable medical device in development to enable routine subcutaneous administration of therapeutics to the cerebrospinal fluid First stage of the pivotal ...
Abstract PURPOSE: Implantable intrathecal drug delivery systems (IDDSs) have been used to manage refractory cancer pain, but there are no randomized clinical trial (RCT) data comparing them with ...
Alcyone’s ThecaFlex DRx™ System is an implantable medical device in development for intrathecal drug delivery The ThecaFlex DRx™ System has the potential to be the first implantable device designed to ...
No one is looking in the rearview mirror at Medtronic plc as a fresh U.S. FDA approval for the next generation version of its intrathecal drug delivery system allows the company to leave behind a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results